AstraZeneca has vowed to spend over $10 billion on R&D deals in Asia, focusing on China, amid ongoing fraud scandal ...

Teacher Retirement System of Texas boosted its position in Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 57.6% during ...

Studies abound, but don't always agree on the impact of adding — or removing — fluoride from public drinking water ...

The University of Alabama at Birmingham ’s telehealth division, UAB eMedicine, has recently launched its Online Second ...

Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.

Wyoming Governor Mark Gordon signed Senate Bill 107 into law, fundamentally reshaping the landscape for non-compete agreements in ...

Pediatric airway anomalies represent a diverse range of congenital and acquired conditions frequently requiring surgical intervention. Addressing these ...

Leqembi — sold through a partnership between Eisai Co. and Cambridge-based Biogen — is one of the first medications approved ...

AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

A live audio webcast will be accessible through the Investors section of the Company’s website at www.anavex.com. An archived edition of the session will be available later that day. About Anavex Life ...

AstraZeneca’s Calquence (acalabrutinib) in combination with bendamustine and rituximab has been recommended for approval in the European Union (EU) for the treatment of adult patients with previously ...

A New York doctor reportedly lost her job after she shared a controversial post earlier this month on social media. In a ...